Amyloid assembly and disassembly.

Area of Science:

• Biochemistry
• Neuroscience
• Structural Biology

Background:

• Amyloid fibrils are protein aggregates with diverse structures.
• Some amyloids are implicated in neurodegenerative diseases (e.g., Alzheimer's, Parkinson's), while others have beneficial functions.
• Distinct amyloid strains from the same protein can cause different diseases.

Purpose of the Study:

• To advance understanding of amyloid assembly, structure, and strain diversity.
• To explore mechanisms of deleterious amyloidogenesis, including mutant steric zippers and phase transitions.
• To highlight therapeutic strategies against amyloid formation and toxicity.

Main Methods:

• Review of current research on amyloid structure and assembly.
• Discussion of molecular mechanisms driving toxic amyloid formation.
• Analysis of therapeutic interventions targeting amyloid pathways.

Main Results:

• Distinct amyloid strains can arise from the same protein, leading to varied disease pathologies.
• Mutant steric zippers and aberrant phase transitions contribute to harmful amyloidogenesis.
• Multiple strategies exist to inhibit amyloid formation or promote its degradation.

Conclusions:

• Advances in understanding amyloid structure and assembly are crucial for neurodegenerative disease research.
• Targeting amyloid formation, degradation, and disaggregation offers promising therapeutic avenues.
• Future research inspired by these findings may lead to treatments for fatal neurodegenerative conditions.